baber/WOPTO huggingface dataset:
Patent AU-2002232959-B2 (AU)
Title: Methods and instrumentation for vertebral interbody fusion
Inventor: DERIDDER STEVEN D
IPC: A61F2/00
Filed: 2002-01-03
Granted: 2006-07-13
Abstract: Methods and instrumentation particularly adapted for disc space preparation for insertion of implants from an anterior approach to the spine are provided. The instruments include a guide sleeve defining a channel having overlapping cylindrical working channel portions and lateral non-distracting extensions extending from reduced thickness wall portions. The guide sleeve has an overall reduced width configuration. A pair of distractors are provided. A first distractor includes a shaft and distal tip, each having convex walls. A second distractor includes a shaft and distal tip including a recessed area at least along the tip. The first distractor is at least partially received within the recessed area of the second distractor when the first and second distractors are in side-by-side relation and a reduced overall width of the distractors is obtained. Preferably, the first and second distractors are used with the guide sleeve. Methods using the disclosed instruments are also provided.
Patent AU-2002321038-B2 (AU)
Title: Coated granular material and method for production thereof
Inventor: KUHLMANN PETER
IPC: A01N25/12
Filed: 2002-05-27
Granted: 2007-08-09
Abstract: The invention relates to a coated granular material wherein the coating comprises the reaction product of (A) an acid-modified fatty (acid) component and (B) an epoxide component. The invention furthermore relates to a method for the preparation of coated granular materials comprising the steps (a) providing a granular material, (b) providing a coating material, comprising (A) an acid-modified fatty (acid) component and (B) an epoxide component, (c) adding of the coating material to the provided granular material, (d) generating a coating on the granular material, and (e) optionally repeating steps (c) and (d).
Patent AU-2002359740-B2 (AU)
Title: Methods and apparatus for network congestion control
Inventor: MORANDIN GUGLIELMO M
IPC: G06F15/16
Filed: 2002-12-17
Granted: 2007-11-22
Abstract: Methods and apparatus are provided for controlling congestion in a network such as a fibre channel network. Techniques are provided for characterizing traffic flow at a congested network node. The congested network node can generate various instructions such as quench messages to control traffic flow towards the congested network node. The quench messages can optionally include information about the characteristics of the congestion. The instructions are distributed to other nodes in the network. The other network nodes can interpret the instructions and control traffic flow towards the congested node.
Patent AU-2002361933-B2 (AU)
Title: Blood withdrawal device
Inventor: SARSTEDT WALTER
IPC: A61M1/00
Filed: 2002-12-16
Granted: 2007-08-16
Abstract: A blood-drawing device has a specimen tube having a projecting tip having an outer connection region of a predetermined diameter and a guide sleeve fittable over the tip and having an inner resilient part. The inner resilient part has an inside diameter smaller than the diameter of the connection region. A needle fitted to the guide sleeve is surrounded by an elastomeric tubular needle shield inward from the guide sleeve. The sleeve can move between an outer position with the needle shield extending inward past the inner needle end and the resilient part offset outward from the connection region and an inner position with the needle end in the specimen tube, the needle shield compressed between the sleeve and the specimen tube, and the resilient part fitting tightly around the connection region and deformed outwardly thereby such that the resilient part grips the connection region.
Patent AU-2003294330-B2 (AU)
Title: Methods and apparatus for dynamic session key generation and rekeying in mobile IP
Inventor: LEUNG KENT K
IPC: H04L29/06
Filed: 2003-11-17
Granted: 2009-08-06
Abstract: Methods and apparatus for providing a centralized source of session keys to be shared by a Home Agent and a Mobile Node are disclosed. In accordance with one aspect of the invention, a Mobile Node registers with a Home Agent supporting Mobile IP by sending a registration request to the Home Agent. The Home Agent sends a request message (e.g., access-request message) to a AAA server, the request message identifying the Mobile Node. The AAA server then derives key information from a key or password associated with the Mobile Node. The AAA server then sends a reply message (e.g., access-reply message) to the Home Agent, the reply message including the key information associated with the Mobile Node, thereby enabling the Home Agent to derive a shared key to be shared between the Mobile Node and the Home Agent from the key information. The Home Agent derives a key from the key information, the key being a shared key between the Mobile Node and the Home Agent. A registration reply is then sent to the Mobile Node. When the Mobile Node receives a registration reply from the Home Agent, the registration reply indicates that the Mobile Node is to derive a key to be shared between the Mobile Node and the Home Agent. The Mobile Node then derives a key to be shared between the Mobile Node and the Home Agent from key information stored at the Mobile Node. The Mobile Node may initiate "re-keying" by sending a subsequent registration request to the Home Agent.
Patent AU-2003298939-B2 (AU)
Title: Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
Inventor: WANG HONG
IPC: G01N33/94
Filed: 2003-12-05
Granted: 2007-03-15
Abstract: Methods of inhibiting release of a proinflammatory cytokine from a macrophage are provided. The methods comprise treating the macrophage with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the macrophage, wherein the cholinergic agonist is selective for an ±7 nicotinic receptor. Methods for inhibiting an inflammatory cytokine cascade in a patient are also provided. The methods comprise treating the patient with a cholinergic agonist in an amount sufficient to inhibit the inflammatory cytokine cascade, wherein the cholinergic agonist is selective for an ±7 nicotinic receptor. Methods for determining whether a compound is a cholinergic agonist reactive with an ±7 nicotinic receptor are also provided. The methods comprise determining whether the compound inhibits release of a proinflammatory cytokine from a mammalian cell. Additionally, methods for determining whether a compound is a cholinergic antagonist reactive with an ±7 nicotinic receptor are provided. These methods comprise determining whether the compound reduces the ability of a cholinergic agonist to inhibit the release of a proinflammatory cytokine from a mammalian cell. Oligonucleotides or mimetics capable of inhibiting attenuation of lipopolysaccharide-induced TNF release from a mammalian macrophage upon exposure of the macrophage to a cholinergic agonist are also provided. The oligonucleotides or mimetics consist essentially of a sequence greater than 5 nucleotides long that is complementary to an mRNA of an ±7 receptor. Additionally, methods of inhibiting attenuation of TNF release from a mammalian macrophage upon exposure of the macrophage to a cholinergic agonist are provided. These methods comprise treating the macrophage with the above-described oligonucleotide or mimetic.
Patent AU-2004201366-B2 (AU)
Title: Container seal with flexible central panel
Inventor: KUSUMA DAVID DAUD
IPC: B65D43/02
Filed: 2004-03-31
Granted: 2010-09-23
Abstract: A seal (10) mountable to the rim (14) of an open mouth container (12), the seal (10) including a resiliently flexible central panel (18) separately formed from and intimately bonded to a substantially rigid peripheral mounting ring (16) adapted to snap-mount to the rim (14) of the container (12) with the central panel (18) being selectively flexible both inward and outward relative to the interior of the container (12) for the accommodation of both overfilled and underfilled conditions through a variation in the head space beneath the mounted seal (10). <IMAGE>
Patent AU-2004216904-B2 (AU)
Title: Treatment of sinusitis related chronic facial pain and headache with botulinum toxin
Inventor: BORODIC GARY E
IPC: A61K39/38
Filed: 2004-03-08
Granted: 2009-12-24
Abstract: The present invention provides methods for treating sinus-evoked headaches using botulinum toxin injected or applied in multiple subcutaneous locations over divisions of the trigeminal nerve in soft tissues and dermatomes overlying the corresponding effected sinuses implicated in the etiology of the pain.
Patent AU-2004238648-B2 (AU)
Title: Process for producing liquid and, optionally, gaseous products from gaseous reactants
Inventor: PETER STEYNBERG ANDRE
IPC: C10G2/00
Filed: 2004-05-12
Granted: 2009-05-14
Abstract: An installation for producing liquid and, optionally, gaseous products from gaseous reactants. The installation has a reactor vessel having a vertically extending slurry bed zone; a first gas inlet in the vessel at a low level within the slurry bed zone for introducing gaseous reactants; a second gas inlet in the vessel at a level within the slurry bed zone which is above the first gas inlet for introducing recycled gas, the second gas inlet in the vessel being above the lower 20% of the vertical height of the slurry bed zone; a gas outlet in the vessel above the slurry bed zone, for withdrawing gas from a head space above the slurry bed zone and a liquid outlet in the vessel within the slurry bed zone, for withdrawing liquid product from the vessel.
Patent AU-2004239035-B2 (AU)
Title: Arrangement for guiding the deadlocking of a latch bolt in a door lock
Inventor: RAATIKAINEN JUHA
IPC: E05B55/00
Filed: 2004-04-27
Granted: 2009-09-24
Abstract: A door lock includes a latch bolt and an auxiliary bolt. A stop member is supported by the auxiliary bolt and is movable relative to the auxiliary bolt between a position in which it prevents a guide element moving to a position providing deadlocking of the latch bolt, while the auxiliary bolt is in a protruding position, and a position in which it allows the guide element to move to a position providing the deadlocking of the latch bolt. The stop member allows the guide element to move to the position providing deadlocking of the latch bolt only in case both the auxiliary bolt and the latch bolt are first moved to retracted positions.
Patent AU-2004244732-B2 (AU)
Title: Tobacco mixture and cigarette containing said tobacco mixture
Inventor: WOLFGRAMM REGINE
IPC: A24B13/00
Filed: 2004-06-01
Granted: 2007-07-05
Abstract: The invention relates to an American Blend -type tobacco mixture containing up to 70 percent by weight of Virginia tobaccos, up to 40 percent by weight of Burley tobaccos, up to 20 percent by weight of oriental tobaccos, and up to 5 percent by weight of other types of tobacco, up to 60 percent by weight of which can be provided as swelling tobacco. According to the invention, all or most of the Burley tobacco is provided as cut reconstituted tobacco foil which is obtained according to the TSNA adsorption method. Preferably, at least 60 percent by weight of the Burley tobacco of the reconstituted tobacco foil consists of lamina while the reconstituted tobacco foil is preferably obtained according to a papermaking method. The invention further relates to cigarettes containing such cut tobacco mixtures.
Patent AU-2005202586-B2 (AU)
Title: Method and device for sampling and analyzing interstitial fluid and whole blood samples
Inventor: CHAMBERS GARRY
IPC: A61B10/00
Filed: 2005-06-14
Granted: 2007-03-01
Abstract: The invention disclosed in this application is a method and device (10) for combining the sampling and analyzing of sub-dermal fluid samples, e.g., interstitial fluid or whole blood, in a device suitable for hospital bedside and home use. The device includes a dermal layer penetration probe (12) in fluid communication with an analysis chamber (20). It is applicable to any analyte that exists in a usefully representative concentration in the fluid, and is especially suited to the monitoring of glucose.
Patent AU-2005252868-B2 (AU)
Title: Detection of methamphetamine group drugs
Inventor: JEHANLI AHMED MOHAMMED TAKI
IPC: C07K14/765
Filed: 2005-06-10
Granted: 2011-02-03
Abstract: The present invention provides immunoassays which are highly specific for detection in biological samples of methamphetamine and other drugs of abuse of the methamphetamine group such as ecstasy and other ecstasy class drugs. More particularly, competitive assays are provided comprising: (a) contacting said sample with (i) a pseudoephedrine/carrier conjugate in which pseudoephedrine is linked via its hydroxyl group to the carrier and (ii) an antibody which is capable of binding both one or more drugs of the methamphetamine group and said conjugate; and (b) determining whether the binding of said antibody to said conjugate is reduced by the presence of said sample, a reduction in binding being indicative that the sample contains a methamphetamine group drug.
Patent AU-2005260816-B2 (AU)
Title: Method of crystallizing bicalutamide
Inventor: KATSURA TADASHI
IPC: C07C317/46
Filed: 2005-07-13
Granted: 2010-12-16
Abstract: The present invention provides a method of crystallization of bicalutamide comprising adding an acetone solution containing bicalutamide to water; crystals of bicalutamide wherein particle size distribution of the crystals is 1 to 10µm of Dp 10 , 10 to 25 µm of Dp 50  and 25 to 100 µm of Dp 90 , and the crystals are obtainable by the method described above; and crystals of bicalutamide, wherein particle size distribution of the crystals is 1 to 3 µm of Dp 10 , 2 to 5 µm of Dp 50  and 5 to 15 µm of Dp 90 .
Patent AU-2006236933-B2 (AU)
Title: Floor finish stripper composition that thickens following dilution with water and method of stripping
Inventor: LI MINYU
IPC: C09D9/00
Filed: 2006-04-06
Granted: 2010-01-14
Abstract: Floor finishes can be stripped using a substantially nonchlorinated concentrate comprising a floor finish dissolver and an at least partially water-unactivated water thickener. The concentrate is diluted with water at an intended use location to activate the water thickener and noticeably increase within sixty minutes or less the viscosity of the resulting mixture, then applied to a hardened floor finish atop a floor and allowed to soften or dissolve the floor finish so that the finish may be removed from the floor.
Patent AU-2006242596-B2 (AU)
Title: Suspended floorboard
Inventor: LAMBERT BRIAN M
IPC: B62D33/06
Filed: 2006-04-27
Granted: 2012-08-02
Abstract: A materials handling vehicle (10) is provided comprising: a frame (14) ; a set of wheels (16, 18) supported on the frame to allow the materials handling vehicle to move across a floor surface; a rider compartment located within the frame for receiving an operator; and an operator support assembly (100). The operator support assembly comprises a suspended floorboard (110) upon which the operator may stand when located within the rider compartment and an energy absorbing structure coupled to the frame and the suspended floorboard for absorbing and dissipating at least a portion of energy resulting from disturbances encountered by the vehicle as it moves across the floor surface prior to the energy portion reaching the operator standing on the suspended floorboard, the energy absorbing structure including a damping element (144, 244, 344, 444, 544, 650, 740, 944) for effecting a damping function.
Patent AU-2006250828-B2 (AU)
Title: Modulation of plant growth by altering amino acid uptake
Inventor: HENRIK SVENNERSTAM
IPC: A01H5/00
Filed: 2006-05-26
Granted: 2011-10-27
Abstract: This invention relates to finding that plant growth is directly affected by alterations in the expression of amino acid transporters that mediate the uptake of amino acids from the environment. Methods of modulating plant growth by modulation of amino acid transporter expression are provided.
Patent AU-2006254651-B2 (AU)
Title: Tyne replacement indicator
Inventor: DAVIES BRIAN
IPC: E02F3/40
Filed: 2006-06-02
Granted: 2012-04-05
Abstract: A system (10) for detecting the required replacement of tynes/teeth (14,16) of an earth digger comprising a capsule (32) of fluid (38) which changes to a gas form when released. Wear or breakage causes the embedded capsule, supported by resin (42) and holder (44) to break, releasing the fluid to be detected by a nearby gas analyser, which raises an alarm.
Patent AU-2006280479-B2 (AU)
Title: Shoe insole
Inventor: FREDERICKSEN RAY M
IPC: A43B7/22
Filed: 2006-04-20
Granted: 2011-07-14
Abstract: An insole providing cushioning and control of foot motion. The insole includes a stability cradle and a number of pods on the underside of the insole core or base. Some of the pods have different material properties selected to help control foot motion.
Patent AU-2006304100-B2 (AU)
Title: Anti-glypican-3 antibody
Inventor: SUGO IZUMI
IPC: A61P35/00
Filed: 2006-10-11
Granted: 2013-03-07
Abstract: An anti-glypican-3 antibody comprising one or more amino acid substitutions introduced in the Fc region is disclosed. Preferably, in the anti-glypican-3 antibody, one or more of the amino acid residues at the positions 239, 298, 326, 330 and 332 in the Fc region are substituted with other amino acid residues. Since the Fc-modified anti-glypican-3 antibody of the invention exhibit enhanced ADCC activity, it is useful in treating cancers, such as hepatic cancer. Also disclosed are an anticancer agent comprising the anti-glypican-3 antibody of the invention and a pharmaceutically acceptable carrier, as well as a method of treating a patient with cancer comprising administering to the patient the anticancer agent of the invention.
Patent AU-2006308534-B2 (AU)
Title: Bone matrix compositions and methods
Inventor: BEHNAM KEYVAN
IPC: A61L27/46
Filed: 2006-11-01
Granted: 2013-02-07
Abstract: An osteoinductive composition, corresponding osteoimplants, and methods for making the osteoinductive composition are disclosed. The osteoinductive composition comprises osteoinductive factors, such as may be extracted from demineralized bone, and a carrier. The osteoinductive composition is prepared by providing demineralized bone, extracting osteoinductive factors from the demineralized bone, and adding the extracted osteoinductive factors to a carrier. Further additives such as bioactive agents may be added to the osteoinductive composition. The carrier and osteoinductive factors may form an osteogenic osteoimplant. The osteoimplant, when implanted in a mammalian body, can induce at the locus of the implant the full developmental cascade of endochondral bone formation including vascularization, mineralization, and bone marrow differentiation. Also, in some embodiments, the osteoinductive composition can be used as a delivery device to administer bioactive agents.
Patent AU-2006312409-B2 (AU)
Title: Support assembly
Inventor: MARSHALL PETER ANTHONY
IPC: F16B45/00
Filed: 2006-11-10
Granted: 2012-04-19
Abstract: L'invention concerne un ensemble pour soutenir un article ; il possède un logement (11) présentant une première surface (23), une seconde surface (25) opposée à la première et une périphérie (27) entre la première et la seconde surface. Une ouverture (33) est située sur la première surface du logement et une cavité (35) se prolonge vers l'intérieur depuis l'ouverture. Au moins une surface de contact (42) est située dans la cavité et positionnée vers la seconde surface ; elle est conçue pour créer une première zone de support. Un élément (7) servant à supporter l'article est conçu pour venir en contact avec la ou les surfaces de contact (43) du logement, une partie de cet élément de support se prolongeant depuis l'ouverture (33) du logement et étant soutenue par une seconde zone de suppot sur ou vers la première surface du logement, pour soutenir l'article. Elle concerne également une unité de base et un élément de support.
Patent AU-2006322316-B2 (AU)
Title: Method for the diagnosis and treatment of cardiovascular diseases
Inventor: THOMAS LEEUW
IPC: C12Q1/68
Filed: 2006-11-23
Granted: 2011-11-03
Abstract: The present invention refers to a method for the or diagnosis of cardiovascular diseases, in particular high blood pressure, stenosis, vessel occlusion and/or other thrombotic events, wherein the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein of a sample of a person is determined as well as to the use of ARK2 for the development and/or production of a medicament for treating a cardiovascular disease.
Patent AU-2006331608-B2 (AU)
Title: Heterocyclic derivatives as modulators of ion channels
Inventor: KAWATKAR AARTI
IPC: C07D417/14
Filed: 2006-12-21
Granted: 2012-07-05
Abstract: The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Patent AU-2006335700-B2 (AU)
Title: Modular container system
Inventor: RODRIGUES MANUEL MARIA
IPC: A01G9/02
Filed: 2006-01-23
Granted: 2012-07-12
Abstract: The present invention relates to a modular container system for use in agriculture, gardening and construction, characterised in that it comprises a parallelepiped container 1 with two partition walls 2 forming three chambers 3, its top ends each having a sleeve 4 which forms a vertical channel 5, the lower end 6 of the said sleeve extending beyond the bottom of the container but with slightly smaller dimensions and having a groove 10 around its whole periphery; connectors 9 which join adjacent containers in a horizontal plane; a base 11 which allows the containers to rest on the ground; and a lateral support 13 exactly identical to the top end of the container 1.
Patent AU-2007207044-B2 (AU)
Title: Concentration of suspensions
Inventor: PAUL STOCKS
IPC: B01D21/01
Filed: 2007-01-04
Granted: 2011-11-10
Abstract: The present invention relates to a process of concentrating an aqueous suspension of solid particles comprising the steps of adding at least one organic polymeric flocculant to the suspension thereby forming flocculated solids in which the flocculated solids are allowed form a layer of solids and thereby forming a more concentrated suspension in which the process comprises the addition of an effective amount of an agent that is selected from the group consisting of free radical agents, oxidising agents, enzymes and radiation, in which the agent is applied to the suspension prior to or substantially simultaneously with adding the organic polymeric flocculant and/or the organic polymeric flocculant is added to the suspension in a vessel and the agent is applied to the suspension in the same vessel. The process is particularly suitable for solids liquid separation in which the flocculated solids are allowed to settle by sedimentation in a gravity thickener.
Patent AU-2007223391-B2 (AU)
Title: Method for demonstrating pre-emergent pimples
Inventor: KOLLIAS NIKIFOROS
IPC: A61B5/103
Filed: 2007-03-02
Granted: 2012-06-07
Abstract: A method for demonstrating pre-emergent pimples is disclosed. The method includes providing a camera having a 25 mm macro lens and a linear polarizing filter including from 10 to 50 narrow band filters in the spectral range of 400-970 nm, and a light source having a linear polarizer oriented vertical to a polarization plane of the camera polarizer; taking a sequence of images of the face of a subject with the camera; creating an erythema map of the imaged area using oxy-hemoglobin values at each corresponding pixel; taking a visible-light image of the face of the subject; and comparing the images to see pre-emergent pimples. The method enables consumers to see pre-emergent pimples and treat them, which results in preventing the pimples from emerging or reducing the emergence of the pimples.